Quality Management Systems
Drug manufacturing sites in FDA's CDER Site Catalog worldwide
PIC/S Participating Authorities enforcing harmonized GMP standards
FDA warning letters to drug manufacturers in 2025 alone
Regulation Overview
FDA.gov, EMA.europa.eu, PICScheme.org, ICH.org
Good Manufacturing Practice is the global baseline for pharmaceutical, biotechnology, and medical device manufacturing quality. For supply chain and compliance teams, GMP compliance centers on maintaining validated processes, controlled documentation, qualified suppliers, and continuous audit readiness across every manufacturing site and supplier in the network.
GMP requirements are enforced by over 57 national regulatory authorities through PIC/S harmonization. FDA's CDER alone monitors over 4,800 drug manufacturing sites worldwide, and CDER warning letters rose 50% in FY2025—with 35% citing GMP manufacturing failures and 15% flagging data integrity violations. Companies manufacturing or sourcing regulated products must demonstrate pharmaceutical quality management through validated processes, traceable records, qualified personnel, and rigorous supplier oversight.
GMP compliance requires site-level and supplier-level evidence—certificates, audit reports, CAPA records, and qualification documentation—from every node in the supply chain. When regulations update, your entire supplier network requires reassessment.
Pharmaceutical manufacturers of drug substances and drug products
Medical device manufacturers placing products on US or EU markets
Biotechnology companies producing biologics and ATMPs
Contract manufacturing organizations (CMOs) and CDMOs
API manufacturers and suppliers in regulated supply chains
Importers and distributors of GMP-regulated products
Key Thresholds
Your products ship to 12 markets, each with a different GMP authority. FDA expects 21 CFR 211 compliance. The EMA requires EU GMP Annex 1 adherence. PIC/S harmonizes some requirements but not all. Your team maintains separate documentation sets for each jurisdiction, manually cross-referencing audit findings against different regulatory expectations—while regulatory intelligence updates arrive faster than your team can process them.
An FDA inspector issues a Form 483 with six observations. Your quality unit has 15 business days to respond with a credible corrective action plan. But the evidence—supplier certificates, validation records, CAPA documentation—is scattered across shared drives, email attachments, and paper files. Day 14: your response references documents you cannot locate. Day 16: the inspector escalates to a warning letter recommendation.
Your supply chain spans 200 suppliers across three tiers. FDA warning letter trends show that supplier oversight failures are among the most frequently cited GMP violations. But your supplier qualification files are 18 months old. Certificates have expired. Audit reports reference processes that have since changed. Without a centralized compliance data backbone, you cannot demonstrate current supplier qualification status to an inspector.
Data integrity violations appeared in 15% of all 2025 FDA warning letters—with Indian manufacturing sites cited at a 60% rate for data integrity issues. Inspectors look for ALCOA+ compliance across every batch record, lab notebook, and electronic system. Manual, paper-based, or hybrid systems cannot provide the immutable audit trails, access controls, and contemporaneous recording that regulators now demand at scale.
Certivo In Action
Certivo in Action — GMP Workflow
Features Tabs
From Manual Assembly to Exception Management
CORA extracts supplier qualification data automatically through AI document parsing and certificate validation. Your team focuses on exceptions that need human judgment—not manual certificate tracking and document assembly.
Audit Readiness Acceleration
Generate complete, validated inspection documentation packages in hours—not the 4–6 weeks of manual compilation across scattered systems and email archives.
Proactive GMP Compliance Monitoring
When FDA, EMA, PIC/S, or ICH guidelines update, Certivo reassesses your supplier network instantly through regulatory intelligence and horizon scanning. Know which suppliers and products are affected before inspectors arrive.
Frequently Asked Questions
What products and companies are subject to GMP compliance requirements?
Any company manufacturing, processing, or distributing pharmaceutical drug products, medical devices, biologics, or active pharmaceutical ingredients for regulated markets must comply with applicable GMP requirements. This includes contract manufacturers, API suppliers, importers, and distributors. In the US, FDA enforces 21 CFR Parts 210/211 for drugs and the new QMSR (incorporating ISO 13485) for devices. The EU enforces EudraLex Volume 4, and 57 PIC/S participating authorities enforce harmonized GMP standards globally.
What are the penalties for GMP non-compliance?
FDA enforcement actions escalate from Form 483 observations to warning letters, consent decrees, import alerts, product seizures, injunctions, and criminal prosecution. CDER issued 85 warning letters to drug manufacturers in 2025—a 50% increase over FY2024. Warning letters are publicly accessible, creating reputational risk visible to customers, partners, and investors. In the EU, national authorities can suspend manufacturing authorizations and withdraw products from market. CORA helps organizations maintain continuous compliance monitoring to avoid these outcomes.
How does Certivo track updates to GMP regulations across multiple authorities?
Certivo maintains continuous sync with FDA, EMA, PIC/S, ICH, and national regulatory authority updates through built-in regulatory intelligence and horizon scanning. When requirements change—such as the QMSR transition, EU GMP Annex revisions, or new ICH guideline implementations—CORA reassesses your supplier network and alerts you to affected qualifications, triggering appropriate re-qualification and documentation workflows automatically.
What supplier document formats does Certivo accept for GMP qualification?
Certivo accepts any format: GMP certificates, ISO 13485 certificates, certificates of analysis, audit reports, CAPA documentation, quality agreements, PDFs, Excel files, and freeform responses. CORA extracts qualification data regardless of format or language through AI document parsing and certificate validation, eliminating the need to standardize supplier inputs across your global supply chain.
Does Certivo support both FDA and EU GMP requirements alongside related quality frameworks?
Yes. Certivo validates against FDA cGMP (21 CFR 210/211), QMSR (ISO 13485), EU GMP (EudraLex Volume 4), PIC/S harmonized standards, and ICH quality guidelines simultaneously. The same supplier submission is also validated against related substance frameworks—REACH, RoHS, TSCA—eliminating duplicate collection campaigns and providing a centralized compliance data backbone across quality and substance requirements.